DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 91 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,807,081 | +11.1% | 4,629,754 | +8.1% | 0.00% | 0.0% |
| Q2 2023 | $51,146,949 | +22.1% | 4,283,664 | +36.8% | 0.00% | 0.0% |
| Q1 2023 | $41,874,585 | -37.4% | 3,131,981 | +0.7% | 0.00% | -50.0% |
| Q4 2022 | $66,905,099 | +27.7% | 3,108,973 | +18.9% | 0.00% | 0.0% |
| Q3 2022 | $52,388,000 | +11.4% | 2,615,441 | -0.4% | 0.00% | +100.0% |
| Q2 2022 | $47,014,000 | +58.7% | 2,626,474 | -12.1% | 0.00% | 0.0% |
| Q1 2022 | $29,625,000 | -42.1% | 2,986,426 | -1.6% | 0.00% | 0.0% |
| Q4 2021 | $51,136,000 | +162.8% | 3,034,777 | +270.1% | 0.00% | – |
| Q3 2021 | $19,461,000 | +38.0% | 820,073 | +32.4% | 0.00% | – |
| Q2 2021 | $14,104,000 | – | 619,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |